Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug. It was withdrawn from the US Canadian and UK markets in 1963 due to a risk of neutropenia.
List of articles in "Drug" category - Page 340
Thonzylamine
Thonzylamine (or neohetramine) is an antihistamine and anticholinergic used as an antipruritic.
Lucatumumab
Lucatumumab is a human monoclonal antibody being investigated for the treatment of various types of cancer like multiple myeloma non-Hodgkin’s or Hodgkin’s lymphoma.This drug was developed by Novartis Pharmaceuticals Corp.
Etaracizumab
Etaracizumab (also known as etaratuzumab[citation needed] MEDI-522 trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma prostate cancer ovarian cancer and […]
Abiraterone
Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) — i.e. prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is […]
Nifuroxazide
Nifuroxazide (INN) is an oral nitrofuran antibiotic patented since 1966 and used to treat colitis and diarrhea in humans and non-humans. It is sold under the brand names Ambatrol Antinal […]
Gantenerumab
Gantenerumab is a monoclonal antibody for the treatment of Alzheimer’s disease. A phase I clinical trial has been conducted in 2006/07.Gantenerumab is currently being evaluated in a prodromal Alzheimer’s Disease […]
Teplizumab
Teplizumab (also known as MGA031 and hOKT3γ1(Ala-Ala)) is a humanized monoclonal antibody that is used as an immunosuppressive drug. The Fc region of this antibody has been engineered to have […]
Ibalizumab
Ibalizumab (TMB-355 previously known as TNX-355) is a non-immunosuppressive monoclonal antibody that binds CD4 the primary receptor for HIV and inhibits the viral entry process. It is being investigated as […]
Canakinumab
Canakinumab (INN trade name Ilaris previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family including interleukin-1 alpha.Canakinumab […]